Cargando…

Improvement of In Vivo Expression of Genes Delivered by Self-Amplifying RNA Using Vaccinia Virus Immune Evasion Proteins

Among nucleic acid–based delivery platforms, self-amplifying RNA (saRNA) vectors are of increasing interest for applications such as transient expression of recombinant proteins and vaccination. saRNA is safe and, due to its capability to amplify intracellularly, high protein levels can be produced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beissert, Tim, Koste, Lars, Perkovic, Mario, Walzer, Kerstin C., Erbar, Stephanie, Selmi, Abderraouf, Diken, Mustafa, Kreiter, Sebastian, Türeci, Özlem, Sahin, Ugur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc. 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737720/ https://www.ncbi.nlm.nih.gov/pubmed/28877647 http://dx.doi.org/10.1089/hum.2017.121

Ejemplares similares

HPV16 RNA-LPX vaccine mediates complete regression of aggressively growing HPV-positive mouse tumors and establishes protective T cell memory
por: Grunwitz, Christian, et al.
Publicado: (2019)

Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses
por: Vogel, Annette B., et al.
Publicado: (2018)

A liposomal RNA vaccine inducing neoantigen-specific CD4(+) T cells augments the antitumor activity of local radiotherapy in mice
por: Salomon, Nadja, et al.
Publicado: (2020)

Local radiotherapy and E7 RNA-LPX vaccination show enhanced therapeutic efficacy in preclinical models of HPV16(+) cancer
por: Salomon, Nadja, et al.
Publicado: (2021)

Dexamethasone premedication suppresses vaccine-induced immune responses against cancer
por: Vormehr, Mathias, et al.
Publicado: (2020)

A Bivalent Trans-Amplifying RNA Vaccine Candidate Induces Potent Chikungunya and Ross River Virus Specific Immune Responses
por: Schmidt, Christin, et al.
Publicado: (2022)

Targeting the tumor mutanome for personalized vaccination therapy
por: Kreiter, Sebastian, et al.
Publicado: (2012)

Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA
por: Moyo, Nathifa, et al.
Publicado: (2018)

Mutated tumor alleles are expressed according to their DNA frequency
por: Castle, John C., et al.
Publicado: (2014)

Confidence-based Somatic Mutation Evaluation and Prioritization
por: Löwer, Martin, et al.
Publicado: (2012)

Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma
por: Castle, John C, et al.
Publicado: (2014)

Racing for a SARS‐CoV‐2 vaccine
por: Türeci, Özlem, et al.
Publicado: (2021)

HLA typing from RNA-Seq sequence reads
por: Boegel, Sebastian, et al.
Publicado: (2012)

A taRNA vaccine candidate induces a specific immune response that protects mice against Chikungunya virus infections
por: Schmidt, Christin, et al.
Publicado: (2022)

In vivo imaging of the immune response upon systemic RNA cancer vaccination by FDG-PET
por: Pektor, Stefanie, et al.
Publicado: (2018)

PLAC1 is essential for FGF7/FGFRIIIb-induced Akt-mediated cancer cell proliferation
por: Roldán, Diana Barea, et al.
Publicado: (2020)

Selective activation of tumor growth-promoting Ca(2+ )channel MS4A12 in colon cancer by caudal type homeobox transcription factor CDX2
por: Koslowski, Michael, et al.
Publicado: (2009)

Retrieval of functional TCRs from single antigen-specific T cells: Toward individualized TCR-engineered therapies
por: Omokoko, Tana, et al.
Publicado: (2015)

Antigen-specific oncolytic MV-based tumor vaccines through presentation of selected tumor-associated antigens on infected cells or virus-like particles
por: Hutzler, Stefan, et al.
Publicado: (2017)

Immunogenicity of stabilized HIV-1 Env trimers delivered by self-amplifying mRNA
por: Aldon, Yoann, et al.
Publicado: (2021)

Molecular Characterization of Virus-induced Autoantibody Responses
por: Ludewig, Burkhard, et al.
Publicado: (2004)

NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cells
por: Wagner, Meike, et al.
Publicado: (2013)

Mutanome Engineered RNA Immunotherapy: Towards Patient-Centered Tumor Vaccination
por: Vormehr, Mathias, et al.
Publicado: (2015)

Comparison of Claudin 18.2 expression in primary tumors and lymph node metastases in Japanese patients with gastric adenocarcinoma
por: Rohde, Christoph, et al.
Publicado: (2019)

An Fc-inert PD-L1×4-1BB bispecific antibody mediates potent anti-tumor immunity in mice by combining checkpoint inhibition and conditional 4-1BB co-stimulation
por: Muik, Alexander, et al.
Publicado: (2022)

Immunological effects and activity of multiple doses of zolbetuximab in combination with zoledronic acid and interleukin-2 in a phase 1 study in patients with advanced gastric and gastroesophageal junction cancer
por: Lordick, Florian, et al.
Publicado: (2023)

Generation of novel oncolytic vaccinia virus with improved intravenous efficacy through protection against complement-mediated lysis and evasion of neutralization by vaccinia virus-specific antibodies
por: Lee, Namhee, et al.
Publicado: (2023)

RNA Vaccination Therapy: Advances in an Emerging Field
por: Kreiter, Sebastian, et al.
Publicado: (2016)

Patient-reported outcomes from the phase II FAST trial of zolbetuximab plus EOX compared to EOX alone as first-line treatment of patients with metastatic CLDN18.2+ gastroesophageal adenocarcinoma
por: Lordick, Florian, et al.
Publicado: (2021)

CIMT 2014: Next waves in cancer immunotherapy - Report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, Germany
por: Diken, Mustafa, et al.
Publicado: (2014)

Small Hero with Great Powers: Vaccinia Virus E3 Protein and Evasion of the Type I IFN Response
por: Szczerba, Mateusz, et al.
Publicado: (2022)

DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity
por: Muik, Alexander, et al.
Publicado: (2022)

mRNA therapeutics in cancer immunotherapy
por: Beck, Jan D., et al.
Publicado: (2021)

Selective modulation of cell surface proteins during vaccinia infection: A resource for identifying viral immune evasion strategies
por: Depierreux, Delphine M., et al.
Publicado: (2022)

CXorf61 is a target for T cell based immunotherapy of triple-negative breast cancer
por: Paret, Claudia, et al.
Publicado: (2015)

Luciferase mRNA Transfection of Antigen Presenting Cells Permits Sensitive Nonradioactive Measurement of Cellular and Humoral Cytotoxicity
por: Omokoko, Tana A., et al.
Publicado: (2016)

Targeting the tumor vasculature with engineered cystine-knot miniproteins
por: Lui, Bonny Gaby, et al.
Publicado: (2020)

CIMT 2013: Advancing targeted therapies—report on the 11th Annual Meeting of the Association for Cancer Immunotherapy, May 14–16 2013, Mainz, Germany
por: Diken, Mustafa, et al.
Publicado: (2013)

Translation of genomics-guided RNA-based personalised cancer vaccines: towards the bedside
por: Boisguérin, V, et al.
Publicado: (2014)

rapmad: Robust analysis of peptide microarray data
por: Renard, Bernhard Y, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_1nu40ddrqlri19986t2uqvav0a